Prof. Giacomo Novara

Curriculum Vitae

Prof. Giacomo Novara

Associate Professor of Urology

Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG)

University of Padova, Italy

🤖 Robotic Surgery 🔬 Urological Oncology 🔭 Functional Urology 🎓 Academic Teaching

Curriculum Vitae

Last updated: May 2026

Born
Palermo, 13 August 1975
Position
Associate Professor of Urology
Affiliation
DiSCOG — University of Padova
European qualification
Fellow of the European Board of Urology (FEBU)
Medical register
Palermo, no. 12665

Education

1994
Classical Secondary School Diploma (60/60)
Liceo Classico "Umberto I", Palermo
2000
MD Degree with Honours (110/110 cum laude)
University of Palermo — 20 July 2000
2001
Licence to practise medicine
University of Palermo — May 2001
2000–2005
Urology Residency with Honours (50/50 cum laude)
University of Verona (Oct 2000 – Jan 2005) and University of Padova (Jan–Dec 2005)

Diploma awarded by the University of Padova, December 2005

50/50 cum laude
Fellow of the European Board of Urology (FEBU)
European Association of Urology
2014
Clinical Fellowship in Robotic Surgery
Onze-Lieve-Vrouwziekenhuis (OLV Hospital), Aalst, Belgium

Under the supervision of Prof. Alexander Mottrie — January–December 2014


Academic and Professional Positions

2008–2014
Assistant Professor of Urology
University of Padova

Clinical activity at the Urology Unit, Padova University Hospital — 19 Dec 2008 – 30 Nov 2014

2014
Deputy Scientific Director
Vattikuti Robotic Surgery Institute, Melle, Belgium

January–December 2014

2014 →
Associate Professor of Urology
University of Padova — DiSCOG

Clinical activity at the Urology Unit, Padova University Hospital — from 1 December 2014 to date

Current position

Editorial appointments

2011–2023
Associate Editor
European Urology — 2023 Impact Factor: 25.3

Official journal of the European Association of Urology (EAU)


Teaching Activity

Prof. Novara has been teaching urology for over 10 years to undergraduate medical and nursing students at the University of Padova (Padova and Treviso campuses) and to residents in multiple postgraduate speciality training programmes, including Urology, Medical Oncology, Gynaecology, and Orthopaedics.

Teaching summary

Teaching context Main courses Period
School of Medicine and Surgery — MD programme (Padova and Treviso campuses) Urology (Integrated Course in Medical-Surgical Specialties 2); elective courses in Robotic Surgery in Urological Oncology and in Scientific Research Methodology 2012/13 – present (400+ hours)
Urology Residency Programme Urinary tract semiology, prostatic pathology, renal tumours, urothelial pathology, PSA and tumour markers, renal transplant reimplantation techniques 2009/10 – present (400+ hours)
Medical Oncology Residency Programme Tumours of the urinary tract 2014/15 – present (100+ hours)
Nursing School (Padova, Treviso, Montecchio Precalcino) Clinical nursing in urology 2015/16 – present (200+ hours)

MD thesis supervision

Supervisor or co-supervisor of 23+ MD theses (academic years 2008/09 – 2023/24).

Full list (23 theses)
  • 2008–09 De Gobbi A. — Predictors of erectile function recovery after radical prostatectomy
  • 2008–09 Minjia A. — Functional outcomes after radical cystectomy with orthotopic ileal neobladder
  • 2008–09 Muzaka R. — Prognostic factors predicting survival in patients with bladder cancer undergoing radical cystectomy: multinational multicentre study
  • 2010–11 Zazzara F. — Pathological outcomes of radical prostatectomy after detection of a minimal focus of prostate cancer on biopsy
  • 2011–12 Meggiato L. — Prognostic factors predicting overall survival in patients with systemic relapse of urothelial disease after radical cystectomy
  • 2012–13 Sguotti P. — Robot-assisted vs open radical prostatectomy for prostate cancer: long-term results of a prospective comparative study
  • 2015–16 Zaborra C. — Conservative management of upper tract urothelial carcinoma: oncological and functional outcomes
  • 2015–16 Leone N. — Haemodynamic changes during robot-assisted radical prostatectomy with the AirSeal system
  • 2017–18 La Bombarda G. — MRI-fusion biopsy in prostate cancer diagnosis: correlation with pathological findings on radical prostatectomy specimens
  • 2017–18 Vedolin C.K. — Lymphocele after transperitoneal robotic radical prostatectomy: incidence, risk factors, prevention and treatment
  • 2017–18 Zuccato C. — Antifibrotic effects of ROCK inhibitor and simvastatin in a cellular model of Peyronie's disease
  • 2018–19 Bonutto A. — Efficacy and safety of intravesical gemcitabine in BCG-refractory non-muscle-invasive bladder cancer
  • 2018–19 Giovannini G. — Impact of immunomodulatory drugs on BCG intravesical therapy efficacy in high-risk NMIBC
  • 2018–19 Settimo D. — Transition from da Vinci Si to da Vinci Xi robotic system in urology
  • 2019–20 Ventura M. — Perioperative outcomes of different surgical approaches to benign prostatic hyperplasia
  • 2020–21 Fumanelli F. — Scintigraphic assessment of residual renal function after robotic partial nephrectomy complicated by selective embolisation
  • 2021–22 Tonet E. — Peri-operative, functional and oncological outcomes of robotic radical cystectomy with intracorporeal urinary diversion
  • 2022–23 Poluzzi A. — Robotic surgery for ureteral strictures
  • 2022–23 Parisotto A. — Retzius-sparing robotic simple prostatectomy for LUTS secondary to benign prostatic enlargement
  • 2023–24 Savio M. — Outcomes of robot-assisted radical cystectomy (RARC)
  • 2023–24 Tonon G. — Rezum™ water vapour therapy for LUTS secondary to benign prostatic enlargement
  • 2023–24 Novelli A. — Peri-operative and functional outcomes of robotic surgery for acquired ureteral strictures
  • 2023–24 Tiberio L. — Oncological and functional outcomes in patients with Von Hippel-Lindau disease-associated renal cell carcinoma

Urology residency thesis supervision

Supervisor or co-supervisor of 16+ urology residency theses (academic years 2008/09 – 2024/25).

Full list (16 theses)
  • 2008–09 Boscolo-Berto R. — Detection rate and predictors of prostate cancer at saturation re-biopsy with 24 cores
  • 2008–09 Lamon C. — Role of anatomical criteria in predicting perioperative complications of nephron-sparing surgery
  • 2009–10 Cargnel C. — Oncological outcomes after open vs laparoscopic nephroureterectomy for upper tract urothelial carcinoma
  • 2014–15 Congregalli A. — Outcomes of robot-assisted radical prostatectomy
  • 2014–15 Zattoni F. — Outcomes of partial nephrectomy in patients with tumour thrombosis: retrospective multi-institutional database
  • 2015–16 La Falce S. — Haemodynamic changes during robot-assisted radical prostatectomy with the AirSeal system
  • 2015–16 Kungulli A. — MRI/ultrasound fusion prostate biopsy: preliminary results for prostate cancer diagnosis
  • 2016–17 Meggiato L. — Diagnostic accuracy of repeated TURP and peripheral zone prostate biopsy in incidental prostate cancer following TURP
  • 2017–18 Lami V. — Haemorrhagic complications after nephron-sparing surgery: prognostic factors in a single-centre experience
  • 2018–19 Motterle G. — Impact of immunomodulatory drugs on BCG immunotherapy efficacy in high-risk non-muscle-invasive bladder cancer
  • 2019–20 Aceti A. — Evaluation of miRNA profiles in newly diagnosed bladder tumours
  • 2021–22 Colbacchini C. — Robot-assisted partial nephrectomy: a single-centre analysis
  • 2021–22 Aiello G. — Post-operative, oncological and functional outcomes of robotic radical cystectomy
  • 2021–22 Mitzman F. — Prevalence, treatment and prognosis of patients with sepsis in a urology teaching tertiary centre
  • 2021–22 Goffo F. — Retzius-sparing radical prostatectomy: perioperative, functional and oncological outcomes
  • 2024–25 Facco M. — Video-endoscopic inguinal lymphadenectomy (VEIL) for squamous cell carcinoma of the penis: five-year single-centre experience

Doctoral supervision

Member of the Doctoral Board of the PhD programme in Clinical and Experimental Oncology and Immunology, University of Padova (cycles 34–40, academic years 2018/19 – 2024/25).

Supervised PhD candidate Dr Fabio Zattoni (cycle XXXI): "The Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy".


Research Activity

Prof. Novara's main research interests lie in urological oncology and functional urology. Priority areas include the study of prognostic factors in prostate, renal, bladder and upper tract urothelial carcinoma, outcomes of robotic surgery applied to oncological and functional urology, and robotic surgical training.

He has been the driving force behind numerous national and international multicentre collaborations, with particular focus on the development of integrated prognostic systems and quality-of-life assessment in patients with urological malignancies.

Main international collaborations


Scientific Output

Prof. Novara's scientific output comprises several hundred original articles, systematic reviews and meta-analyses published in high-impact peer-reviewed international journals, including European Urology, The Lancet Oncology, JAMA Oncology, European Urology Oncology and BJU International.

700+
Scientific publications
↻ updated May 2026
103
H-index
↻ May 2026 · Harzing's Publish or Perish
36,000+
Total citations
↻ May 2026 · Harzing's Publish or Perish
179
G-index
↻ May 2026 · Harzing's Publish or Perish
5,000+
Surgical procedures
20+
Years of clinical activity
📚 All publications on PubMed → 🎓 Google Scholar → 🆔 ORCID →

Congress activity

15 invited lectures at international congresses
27+ invited lectures at national congresses
11 moderated sessions
Invited lectures at international congresses (15 lectures)
CongressVenue and dateTitle
EAU Annual Meeting 2008Milan, 26–29 Mar 2008Highlight session 1: Oncology
Leading Lights in Urology 2009London, 7–9 May 2009Pharmacotherapy of overactive bladder
EAU Annual Meeting 2010Barcelona, 16–20 Apr 2010Looking back in TIME: Meta-analyses and the clinical data
Leading Lights in Urology 2010Baveno, 13–15 May 2010What is new: Surgery for stress incontinence
Belgian Association of Urology 2011Ghent, 9–10 Dec 2011ESU lecture: Evidence based medicine in Urology
EAU Annual Meeting 2011Vienna, 18–22 Mar 2011Case discussion: Management of complications of female incontinence
Leading Lights in Urology 2011Baveno, 7–9 Apr 2011Female mid urethral slings: retropubic vs transobturator vs adjustable
ERUS Annual Meeting 2012London, 27–28 Sep 2012Results on da Vinci prostatectomy: Comparative literature review on perioperative and oncologic outcomes
EAU Annual Meeting 2013Milan, 15–19 Mar 2013Silodosin: A first choice for the pharmacological treatment of BPH — Which patient and why
ERUS Annual Meeting 2014Amsterdam, 17–19 Sep 2014Pasadena consensus: Best practices on RARC — Meta-analysis of outcomes
ERUS Annual Meeting 2015Bilbao, 15–17 Sep 2015Results of pilot study III of EAU Robotic curriculum and follow-up of previous fellows
ERUS Annual Meeting 2016Milan, 14–16 Sep 2016Simple prostatectomy and surgical treatment of bladder diverticula
5th Intl Techno Urology Meeting 2017Orbassano, 25–27 Jan 2017Radiotherapy vs surgery — who is the winner? Face to face
Around the Kidney 2018Milan, 28–29 Nov 2018Predicting the outcome: surgical classification of renal masses
EAU Annual Meeting 2025Madrid, 21–24 Mar 2025Debate: Would patients and physicians be hesitant to use home tests for monitoring low-risk cancers? — No, in-hospital visits
Invited lectures at national congresses (SIU, SIA, AURO.it and others — 27+ lectures)
CongressVenue and dateTitle
SIU 2007Bari, 27 Sep–1 Oct 2007Best of the literature on female stress urinary incontinence
SIU 2008Rome, 22–28 Sep 2008Literature update and new ongoing clinical trials — muscle-invasive bladder cancer
SIU 2009Rimini, 4–7 Oct 2009Degarelix: a new frontier in the treatment of advanced prostate cancer — CON
1st National Medical Conference 2011Florence, 7 May 2011BPH/LUTS therapy according to guidelines
2nd National Medical Conference 2011Florence, 24–25 Nov 2011BPH/LUTS therapy according to guidelines
National Medical Conference 2012Florence, 5–6 Jun 2012Efficacy and tolerability of current therapies for LUTS
SIU 2011Rome, 23–26 Oct 2011Use of intestinal segments in urology: long-term results of ileal neobladder
SIU 2011Rome, 23–26 Oct 2011Are all Serenoa repens extracts equivalent? Critical analysis of the literature
SIU 2012Venice, 21–24 Oct 2012Lights and shadows of the peer-review system: a critical analysis
SIU 2013Riccione, 5–8 Oct 2013Chronic pelvic pain: is the future in OMICS?
SIU 2013Riccione, 5–8 Oct 2013Mirabegron: a new protagonist in the treatment of overactive bladder?
SIA 2013Florence, 18–21 Sep 2013LUTS experience in the patient with erectile dysfunction
SIU 2014Florence, 27–30 Sep 2014Clinical tales of BPH: BPH and elevated PSA
SIU 2015Riccione, 10–13 Oct 2015The role of surgical training for young urologists: training in robotic surgery
SIU 2016Venice, 15–18 Oct 2016Multidisciplinary uro-oncology team: financial management
SIU 2016Venice, 15–18 Oct 2016SIU Highlights 2016: functional and female urology, andrology, infections
AURO.it 2017Pisa, 19–21 May 2017Nephrometry score: why and how to bridge the gap with its limited clinical uptake
SIU 2018Riccione, 13–16 Oct 2018Do the results of the PIVOT trial change clinical practice?
SIU 2018Riccione, 13–16 Oct 2018Developments of the "Multidisciplinary team" project — Prostate
1st Robotic Surgery Meeting 2018Bologna, 31 May–1 Jun 2018Robotic cystectomy: how far are we from standardisation?
SIU 2019Venice, 12–15 Oct 2019Precision medicine in prostate cancer: mp-MRI and novel biomarkers
SIURO Lombardo-Veneto 2020Bergamo, 24 Jan 2020Natural history and rationale for active surveillance of small renal masses
SIU 2020Rome, 17–18 Oct 2020Role of telemedicine: myth or reality?
SIU VI Masterclass in Uro-Oncology 202520 Jun 2025Partial cystectomy
Triveneto Urology Meeting 2025Treviso, 11 Oct 2025Keynote lecture: prostate cancer
SIU 2025Sorrento, 6–9 Nov 2025Debate: Active surveillance for favourable intermediate-risk prostate cancer — Against
SIU Webinar — Bladder Cancer 202618 Feb 2026Surgical strategy in muscle-invasive bladder cancer
NMIBC: current approaches and future scenarios 2026Pavia, 18 Apr 2026Follow-up strategies: striking the right balance between recurrence detection and overtreatment
SIU VII Masterclass in Uro-Oncology 20263 Jul 2026Indications and template for lymphadenectomy during nephroureterectomy

Awards & Honours

National and international recognition

  • 2008Awarded as Reviewer of the Month by European Urology (July 2008).
  • 2010Awarded as Reviewer of the Year by European Urology.
  • 2010European Urology Best Scientific Paper Prize — V. Ficarra, G. Novara et al. «Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery». European Urology 2009;56:786–793.
  • 2011Best Abstract, EAU Annual Meeting – Poster session 42 «RCC: diagnosis and prognosis». G. Novara: «Head to head comparison of the most relevant integrated prognostic systems predicting cancer-specific survival in clear cell renal cell carcinoma».
  • 2011Best Abstract, EAU Annual Meeting – Poster session 51 «RCC: nephron-sparing surgery». G. Novara: «Partial and radical nephrectomy for pT1 renal cell carcinoma: results of the Saturn project».
  • 2013European Urology Prize for the Best Paper on Clinical Research — S. Shariat, M. Rink, G. Novara et al. «Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy». European Urology 2012.
  • 2013European Urology Prize for the Best Scientific Paper by a Young Urologist (≤35 years) — M. Rink, G. Novara et al. «Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery». European Urology 2012;62(4):677–684.
  • 2015Winner of the Italian Matula Award at the Annual Congress of the Società Italiana di Urologia (SIU).
  • 2017Best Poster, EAU Annual Meeting – Session 79 «Challenges in minimally invasive partial nephrectomy». F. Zattoni, R.H. Thompson, G. Novara et al.: «Partial nephrectomy in the treatment of renal tumors with concomitant venous tumor thrombosis of renal vein branches».

Contacts

For clinical enquiries, research collaborations or academic matters

📞
Secretary+39 049 821 1250
🏥
Clinical address

Urology Unit, Padova University Hospital
Via Giustiniani 2, 35128 Padova, Italy

www.aopd.veneto.it →
🎓
Academic address

DiSCOG — University of Padova
Via Giustiniani 2, 35128 Padova, Italy

DiSCOG profile →

⚠️ The information on this website is intended for educational purposes only. It does not constitute medical advice and does not establish a doctor-patient relationship. For any personal clinical matter, please consult your physician or book a specialist appointment. Full medical disclaimer →